Inventor · disambiguated record
Daniel S. Rivera
Also filed as: RIVERA DANIEL · RIVERA DANIEL S · RIVERA DANIEL SANTOS · RIVERA SR DANIEL
32 granted patents·13 pending applications·1,248 citations·filing 1990–2024
98Inventor score
Files withEPIVAX INC18BIOVERATIV THERAPEUTICS INC8ADC TELECOMMUNICATIONS INC3BIOGEN IDEC HEMOPHILIA INC3RIVERA DANIEL3
Top patents by PatentIndex Score
45 records- 0198US7884184B2Regulatory T cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2008·Granted Feb 8, 2011·72 cites·13 claims
- 0298US7862820B2Immunoglobulin chimeric monomer-dimer hybridsSYNTONIX PHARMACEUTICALS INC·Filed 2006·Granted Jan 4, 2011·120 cites·13 claims
- 0398US7404956B2Immunoglobulin chimeric monomer-dimer hybridsSYNTONIX PHARMACEUTICALS INC·Filed 2004·Granted Jul 29, 2008·301 cites·48 claims
- 0498US7348004B2Immunoglobulin chimeric monomer-dimer hybridsSYNTONIX PHARMACEUTICALS INC·Filed 2005·Granted Mar 25, 2008·218 cites·20 claims
- 0596US8449884B2Clotting factor-fc chimeric proteins to treat hemophiliaRIVERA DANIEL S·Filed 2010·Granted May 28, 2013·65 cites·24 claims
- 0696US8329182B2Immunoglobulin chimeric monomer-dimer hybridsPETERS ROBERT T·Filed 2010·Granted Dec 11, 2012·82 cites·38 claims
- 0795US9636416B2Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2014·Granted May 2, 2017·20 cites·22 claims
- 0894US8932830B2Immunoglobulin chimeric monomer-dimer hybridsBIOGEN IDEC HEMOPHILIA INC·Filed 2012·Granted Jan 13, 2015·25 cites·27 claims
- 0993US8815250B2Clotting factor-Fc chimeric proteins to treat hemophiliaBIOGEN IDEC HEMOPHILIA INC·Filed 2013·Granted Aug 26, 2014·19 cites·24 claims
- 1091US5582525ADrop and insert cardADC TELECOMMUNICATIONS INC·Filed 1995·Granted Dec 10, 1996·94 cites·9 claims
- 1191US5199878APlug-in jack card for normally closed contactsADC TELECOMMUNICATIONS INC·Filed 1990·Granted Apr 6, 1993·167 cites·9 claims
- 1290US10980867B2Regulatory T cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2019·Granted Apr 20, 2021·3 cites·10 claims
- 1390US10925942B2Regulatory T cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2019·Granted Feb 23, 2021·3 cites·10 claims
- 1490US9725496B1Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2017·Granted Aug 8, 2017·4 cites·27 claims
- 1589US10925939B2Regulatory T cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2018·Granted Feb 23, 2021·3 cites·10 claims
- 1689US10925941B2Regulatory T cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2018·Granted Feb 23, 2021·3 cites·10 claims
- 1789US10925940B2Regulatory T cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2018·Granted Feb 23, 2021·3 cites·10 claims
- 1889US10751397B2Regulatory T cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2018·Granted Aug 25, 2020·3 cites·10 claims
- 1988US10213496B2Regulatory T cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2015·Granted Feb 26, 2019·3 cites·10 claims
- 2087US11168125B2Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Nov 9, 2021·1 cites·10 claims
- 2184US2023023927A1Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2283US11045528B2Regulatory T cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2018·Granted Jun 29, 2021·1 cites·19 claims
- 2383US11045530B2Regulatory T cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2018·Granted Jun 29, 2021·1 cites·19 claims
- 2483US11045532B2Regulatory T cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2018·Granted Jun 29, 2021·1 cites·19 claims
- 2583US11045529B2Regulatory T cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2018·Granted Jun 29, 2021·1 cites·19 claims
- 2683US11045531B2Regulatory T cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2018·Granted Jun 29, 2021·1 cites·19 claims
- 2783US2022211827A1Regulatory t cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2022·Application pending·0 cites
- 2882US2022010000A1Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2980US12016909B2Regulatory T cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2021·Granted Jun 25, 2024·0 cites·19 claims
- 3080US11844826B2Regulatory T cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2021·Granted Dec 19, 2023·0 cites·10 claims
- 3176US2021348150A1Clotting factor-fc chimeric proteins to treat hemophiliaBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3274US8175515B1DTV terrestrial satellite conversion apparatusRIVERA DANIEL·Filed 2008·Granted May 8, 2012·6 cites·18 claims
- 3374US2019351036A1Regulatory t cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2019·Application pending·0 cites
- 3470US11401322B2Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2017·Granted Aug 2, 2022·0 cites·25 claims
- 3564US2015044207A1Clotting Factor-Fc Chimeric Proteins to Treat HemophiliaBIOGEN IDEC HEMOPHILIA INC·Filed 2014·Application pending·0 cites
- 3664US2018237762A1Clotting factor-fc chimeric proteins to treat hemophiliaBIOVERATIV THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3764US2024263063A1High-temperature thermochemical energy storage materials using doped magnesium-transition metal spinel oxidesMUHICH CHRISTOPHER·Filed 2024·Application pending·0 cites
- 3862US2025391667A1Method and apparatus for damascene etchingTOKYO ELECTRON LTD·Filed 2024·Application pending·0 cites
- 3961US2011182921A1Regulatory t cell epitopes, compositions and uses thereofEPIVAX INC·Filed 2010·Application pending·0 cites
- 4059US5078624ADigital signal cross-connect moduleADC TELECOMMUNICATIONS INC·Filed 1991·Granted Jan 7, 1992·28 cites·12 claims
- 4159US2005147618A1Clotting factor-Fc chimeric proteins to treat hemophiliaFiled 2004·Application pending·0 cites
- 4254US11959011B2High-temperature thermochemical energy storage materials using doped magnesium-transition metal spinel oxidesMUHICH CHRISTOPHER·Filed 2021·Granted Apr 16, 2024·0 cites·9 claims
- 4354US2025259570A1Tubular Sign FrameRIVERA DANIEL·Filed 2024·Application pending·0 cites
- 4442US6730481B2Primers-attached vector elongation (PAVE): a 5′-directed cDNA cloning strategyINST GENETICS LLC·Filed 2001·Granted May 4, 2004·0 cites·1 claims
- 4533US2018364071A1Photonic computer system comprised of stack disk arrays running on but not limited to quantum softwareRIVERA DANIEL·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel S. Rivera files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →